The angiotensin II receptor blocker (ARB) candesartan cilexetil decreases portal vascular resistance in liver cirrhosis

被引：0
|
作者：
Ito, M
Hachiya, A
Nakano, S
Hanzawa, M
Katagiri, M
Kurita, T
Matsuzaki, H
Igarashi, Y
Iida, K
Miki, K
机构：
来源：
GASTROENTEROLOGY | 2003年 / 124卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(03)83358-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A663 / A663
页数：1
相关论文
共 50 条
  • [31] In vivo blockade of angiotensin II receptor binding in rat kidney comparison of candesartan cilexetil with losartan
    Fabiani, ME
    Dinh, DT
    Nassis, L
    Johnston, CI
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (04) : 112A - 112A
  • [32] THE ANGIOTENSIN RECEPTOR BLOCKER VALSARTAN ALLEVIATES THE INCREASED INTRAHEPATIC VASCULAR RESISTANCE AND DECREASES LIVER DAMAGE IN A RAT MODEL OF SEVERE STEATOSIS
    van der Graaff, Denise
    Kwanten, Wilhelmus J.
    De Winter, Benedicte Y.
    De Man, Joris
    Michielsen, Peter
    Francque, Sven M.
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S1441 - S1441
  • [33] Discovery of a new class of antihypertensive agents, nonpeptide angiotensin II receptor antagonists : Candesartan cilexetil
    Naka, T
    [J]. NIPPON NOGEIKAGAKU KAISHI-JOURNAL OF THE JAPAN SOCIETY FOR BIOSCIENCE BIOTECHNOLOGY AND AGROCHEMISTRY, 2000, 74 (07): : 787 - 790
  • [34] Effects of high dose angiotensin II receptor blocker - comparison of Valsartan and Candesartan
    Ohishi, Mitsuru
    Ito, Norihisa
    Takagi, Takashi
    Terai, Minako
    Tatara, Yuji
    Shiota, Atsushi
    Hayashi, Norihiro
    Katsuya, Tomohiro
    Rakugi, Hiromi
    Ogihara, Toshio
    [J]. JOURNAL OF HYPERTENSION, 2006, 24 : 364 - 364
  • [35] The angiotensin II type 1 receptor blocker candesartan attenuates graft vasculopathy
    Yamamoto, T
    Fukuda, D
    Takamoto, S
    [J]. CIRCULATION, 2005, 112 (17) : U263 - U263
  • [36] Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in liver cirrhosis.
    Schneider, AW
    Kalk, JF
    Klein, CP
    [J]. HEPATOLOGY, 1998, 28 (04) : 510A - 510A
  • [37] Effect of the angiotensin II type 1 receptor blocker candesartan on cardiovascular events
    Kondo, J
    Sone, T
    Tsuboi, H
    Mukawa, H
    Morishima, I
    Uesugi, M
    Kosaka, T
    Yoshida, T
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 320A - 320A
  • [38] Effect of the angiotensin II receptor blocker candesartan on fibrinolysis in patients with mild hypertension
    Skurk, T
    Lee, YM
    Nicuta-Rölfs, TO
    Haastert, B
    Wirth, A
    Hauner, H
    [J]. DIABETES OBESITY & METABOLISM, 2004, 6 (01): : 56 - 62
  • [39] Effectiveness of angionten II receptor blocker (ARB), candesartan, in the treatment of hormone refractory prostate cancer (HRPC).
    Uemura, H
    Miyoshi, Y
    Ishiguro, H
    Nakaigawa, N
    Noguchi, K
    Kubota, Y
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 410S - 410S
  • [40] Acute Treatment with Candesartan Cilexetil, an Angiotensin II Type 1 Receptor Blocker, Improves Insulin Sensitivity in High-Fructose-Diet-fed Rats
    Li, P.
    Koike, T.
    Jiang, H. Y.
    Wang, Z. H.
    Kawata, Y.
    Oshida, Y.
    [J]. HORMONE AND METABOLIC RESEARCH, 2012, 44 (04) : 286 - 290
12345